Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals has announced the retirement of its Non-Executive Director and Co-Founder, Andreas Kluge, from the company’s board. While stepping down, Kluge will continue to support Telix in a consultancy role, leveraging his expertise in the clinical development of radiopharmaceuticals. His departure marks a significant moment for the company, as it prepares for future growth and new board appointments.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
